Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
ESAT-6–dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo
Andreas Kupz, … , Roland Brosch, Stefan H.E. Kaufmann
Andreas Kupz, … , Roland Brosch, Stefan H.E. Kaufmann
Published April 25, 2016
Citation Information: J Clin Invest. 2016;126(6):2109-2122. https://doi.org/10.1172/JCI84978.
View: Text | PDF
Research Article Infectious disease Article has an altmetric score of 2

ESAT-6–dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo

  • Text
  • PDF
Abstract

IFN-γ is a critical mediator of host defense against Mycobacterium tuberculosis (Mtb) infection. Antigen-specific CD4+ T cells have long been regarded as the main producer of IFN-γ in tuberculosis (TB), and CD4+ T cell immunity is the main target of current TB vaccine candidates. However, given the recent failures of such a TB vaccine candidate in clinical trials, strategies to harness CD4-independent mechanisms of protection should be included in future vaccine design. Here, we have reported that noncognate IFN-γ production by Mtb antigen–independent memory CD8+ T cells and NK cells is protective during Mtb infection and evaluated the mechanistic regulation of IFN-γ production by these cells in vivo. Transfer of arenavirus- or protein-specific CD8+ T cells or NK cells reduced the mortality and morbidity rates of mice highly susceptible to TB in an IFN-γ–dependent manner. Secretion of IFN-γ by these cell populations required IL-18, sensing of mycobacterial viability, Mtb protein 6-kDa early secretory antigenic target–mediated (ESAT-6–mediated) cytosolic contact, and activation of NLR family pyrin domain–containing protein 3 (NLRP3) inflammasomes in CD11c+ cell subsets. Neutralization of IL-18 abrogated protection in susceptible recipient mice that had received noncognate cells. Moreover, improved Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine–induced protection was lost in the absence of ESAT-6–dependent cytosolic contact. Our findings provide a comprehensive mechanistic framework for antigen-independent IFN-γ secretion in response to Mtb with critical implications for future intervention strategies against TB.

Authors

Andreas Kupz, Ulrike Zedler, Manuela Stäber, Carolina Perdomo, Anca Dorhoi, Roland Brosch, Stefan H.E. Kaufmann

×

Figure 2

Innate IFN-γ secretion depends on IL-18 and requires Mtb viability.

Options: View larger image (or click on image) Download as PowerPoint
Innate IFN-γ secretion depends on IL-18 and requires Mtb viability.
(A) ...
(A) Percentage of IFN-γ+ cells among total viable splenic CD3+CD8+, CD3+CD4+, CD3+CD4–CD8– (DN) T cells and CD3–NK1.1+ cells 2 hours after B6 mice were injected with 1 × 108 CFU of either Stm (as a positive control), BCG, HKBCG, Mtb H37Rv, iMtb, or PBS. (B) Percentage of IFN-γ+ cells among total viable splenic CD3+CD8+, CD3+CD4+, CD3+CD4–CD8– (DN) T cells and CD3–NK1.1+ cells at different time points after B6 mice were injected with 1 × 108 CFU Mtb H37Rv. (C) Serum IL-18 concentrations at different time points after injection of B6 mice with 1 × 108 CFU Stm, BCG, Mtb H37Rv, or iMtb H37Rv. (D) Percentage of IFN-γ+ cells among total viable CD3–NK1.1+ in spleen and lung 24 hours after injection of different doses of Mtb H37Rv, BCG, or iMtb H37Rv. (E and F) Percentage of IFN-γ+ CD3–NK1.1+ cells (E) and recoverable CFU (F) from either spleen, lung, or draining LN 24 hours after injection of 1 × 108 CFU Mtb H37Rv via the i.v., i.d., i.t., or s.c. route. Results are presented as pooled data (mean ± SEM) (A–F) and representative FACS plots (E) of 5 to 9 (A), 5 to 10 (B and C), 5 (D), or 7 to 10 (E and F) mice per group from at least 2 to 3 pooled, independent experiments. Dotted lines indicate the mean percentage of the smallest reliably detectable IFN-γ+ response by CD3–NK1.1+ cells (E) and the respective mean recoverable CFU (F) 24 hours after Mtb exposure.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Highlighted by 1 platforms
87 readers on Mendeley
See more details